Cross-Border E-Commerce #glp-1#weight loss drugs
GLP-1 Online Scams Entangle Unsuspecting Patients, Triggering Supply Chain and R
A WIRED investigation into online telehealth provider FitRx/Zealthy reveals a pattern of deceptive billing and shipment of unwanted GLP-1 drugs like tirzepatide. Customers face denied refunds due to 'supply chain and privacy' policies, despite FDA and FTC oversight. The case highlights risks in the booming online weight-loss drug market projected to reach $150 billion.
Jun 12, 2026 1 source
